NCT06762457View on ClinicalTrials.gov

A First-in-Human Single and Multiple Ascending Dose Study of MT-501

PHASE1RecruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

December 11, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Healthy Volunteers
Interventions
DRUG

MT-501

MT-501 Tablets

Trial Locations (1)

92121

RECRUITING

Mirador Clinical Department, San Diego

Sponsors
All Listed Sponsors
lead

Mirador Therapeutics, Inc.

INDUSTRY

NCT06762457 - A First-in-Human Single and Multiple Ascending Dose Study of MT-501 | Biotech Hunter | Biotech Hunter